Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low versus high protamine-to-heparin ratio in cardiac surgery
NL-OMON36910Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Mar 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of protamine and heparin in coagulation defects (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Postoperative 24-hour blood loss. Started Mar 2013; status: active, not recruiting.
02
Drugs
protamineheparin
03
Conditions
coagulation defects
Beyond the preview
Go deeper on NL-OMON36910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36910.